Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Management of hepatic encephalopathy in the hospital
Michael D. Leise
, John J. Poterucha
,
Patrick S. Kamath
, W. Ray Kim
Gastroenterology and Hepatology
Research output
:
Contribution to journal
›
Review article
›
peer-review
58
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of hepatic encephalopathy in the hospital'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatic Encephalopathy
100%
Lactulose
36%
Rifaximin
27%
Covert Hepatic Encephalopathy
27%
Decompensated Cirrhosis
18%
Hospitalized Patients
9%
Human Studies
9%
Hospitalization
9%
Caregivers
9%
Medical Therapy
9%
Gastrointestinal Bleeding
9%
Cirrhosis
9%
Zinc
9%
Motor Vehicle Accident
9%
2-phase
9%
Subspecialists
9%
Maintenance Therapy
9%
Internist
9%
Bowel Movement
9%
PubMed
9%
Medically Refractory
9%
Non-absorbable Antibiotic
9%
Dose Titration
9%
Disaccharides
9%
Mandatory Reporting
9%
Search Terms
9%
Neomycin
9%
Branched-chain Amino Acids
9%
Adverse Effect Profile
9%
Maintenance of Remission
9%
Remission Induction
9%
Molecular Adsorbent Recirculating System
9%
Portosystemic Shunt
9%
Department of Motor Vehicles
9%
L-ornithine-L-aspartate
9%
Non-absorbable Disaccharides
9%
Medicine and Dentistry
Hepatic Encephalopathy
100%
Lactulose
28%
Rifaximin
21%
Liver Cirrhosis
14%
Disaccharide
14%
Adverse Event
7%
Infection
7%
Human Study
7%
Combination Therapy
7%
Gastrointestinal Bleeding
7%
Maintenance Therapy
7%
Aspartic Acid
7%
Decompensated Liver Cirrhosis
7%
Drug Dose Titration
7%
Mandatory Reporting
7%
Neomycin
7%
Motor Vehicle Accident
7%
Ornithine
7%
Branched Chain Amino Acid
7%
Antibiotics
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatic Encephalopathy
100%
Lactulose
28%
Rifaximin
21%
Liver Cirrhosis
14%
Disaccharide
14%
Adverse Event
7%
Infection
7%
Human Study
7%
Combination Therapy
7%
Remission
7%
Gastrointestinal Hemorrhage
7%
Antibiotics
7%
Aspartic Acid
7%
Decompensated Liver Cirrhosis
7%
Mandatory Reporting
7%
Neomycin
7%
Ornithine
7%
Branched Chain Amino Acid
7%